A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults

2010350 citationsJournal Articlebronze Open Access

Authors

Neil French · London School of Hygiene & Tropical Medicine

Stephen B. Gordon · University of Liverpool

Thandie S. Mwalukomo

Sarah White · University of Liverpool

Gershom Mwafulirwa · University of Liverpool

Herbert Longwe · University of Liverpool

Martin Mwaiponya

Eduard E. Zijlstra

Abstract

The 7-valent pneumococcal conjugate vaccine protected HIV-infected adults from recurrent pneumococcal infection caused by vaccine serotypes or serotype 6A. (Current Controlled Trials number, ISRCTN54494731.)

Topics & Keywords

Pneumonia and Respiratory Infections Pneumocystis jirovecii pneumonia detection and treatment Respiratory viral infections research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 362, Issue 9, pp. 812-822

DOI: 10.1056/nejmoa0903029

Field-Weighted Citation Impact: 22.58